Cargando…
Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan
BACKGROUND: Recurrent bleeding from an intracranial aneurysm after subarachnoid hemorrhage (SAH) is associated with unfavorable outcome. Recurrent bleeding before aneurysm occlusion can be performed occurs in up to one in five patients and most often happens within the first 6 h after the primary he...
Autores principales: | Post, René, Germans, Menno R., Coert, Bert A., Rinkel, Gabriël J. E., Vandertop, W. Peter, Verbaan, Dagmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029526/ https://www.ncbi.nlm.nih.gov/pubmed/32070395 http://dx.doi.org/10.1186/s13063-020-4118-5 |
Ejemplares similares
-
Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial
por: Germans, Menno R, et al.
Publicado: (2013) -
Aneurysm treatment within 6 h versus 6–24 h after rupture in patients with subarachnoid hemorrhage
por: Vergouwen, Mervyn DI, et al.
Publicado: (2023) -
Prehemorrhage antiplatelet use in aneurysmal subarachnoid hemorrhage and impact on clinical outcome
por: Sebök, Martina, et al.
Publicado: (2021) -
Laboratory biomarkers of delayed cerebral ischemia following subarachnoid hemorrhage: A systematic review
por: Tjerkstra, Maud A., et al.
Publicado: (2023) -
Clinical and Laboratory Characteristics for the Diagnosis of Bacterial Ventriculitis After Aneurysmal Subarachnoid Hemorrhage
por: Hoogmoed, J., et al.
Publicado: (2016)